Your browser doesn't support javascript.
loading
Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma.
Borger, Darrell R; Goyal, Lipika; Yau, Thomas; Poon, Ronnie T; Ancukiewicz, Marek; Deshpande, Vikram; Christiani, David C; Liebman, Hannah M; Yang, Hua; Kim, Hyeryun; Yen, Katharine; Faris, Jason E; Iafrate, A John; Kwak, Eunice L; Clark, Jeffrey W; Allen, Jill N; Blaszkowsky, Lawrence S; Murphy, Janet E; Saha, Supriya K; Hong, Theodore S; Wo, Jennifer Y; Ferrone, Cristina R; Tanabe, Kenneth K; Bardeesy, Nabeel; Straley, Kimberly S; Agresta, Sam; Schenkein, David P; Ellisen, Leif W; Ryan, David P; Zhu, Andrew X.
Afiliação
  • Borger DR; Authors' Affiliations: Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston; Agios Pharmaceuticals, Cambridge, Massachusetts; and Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Clin Cancer Res ; 20(7): 1884-90, 2014 Apr 01.
Article em En | MEDLINE | ID: mdl-24478380

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Biomarcadores Tumorais / Colangiocarcinoma / Glutaratos / Isocitrato Desidrogenase Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias dos Ductos Biliares / Biomarcadores Tumorais / Colangiocarcinoma / Glutaratos / Isocitrato Desidrogenase Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article